GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 20 February 2015 of the following increase in the notional allocation of GSK American Depositary Shares (ADSs) on 19 February 2015, at a price of $47.03 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401K plan:
Director/PDMR |
Number of ADSs |
Mr W C Louv |
27 |
Dr M M Slaoui |
20 |
Connected person |
Number of ADSs |
Dr K Slaoui (connected person of Dr M M Slaoui) |
17 |
V A Whyte
Company Secretary
20 February 2015